VNRX VOLITIONRX LTD

NYSE volition.com


$ 0.33 $ -0.01 (-2.38 %)    

Thursday, 20-Nov-2025 15:52:47 EST
QQQ $ 585.47 $ -26.20 (-4.28 %)
DIA $ 458.26 $ -8.42 (-1.8 %)
SPY $ 652.81 $ -20.13 (-2.99 %)
TLT $ 89.28 $ 0.29 (0.33 %)
GLD $ 374.67 $ -0.49 (-0.13 %)
$ 0.3277
$ 0.33
$ 0.32 x 1,500
$ 0.33 x 1,000
$ 0.32 - $ 0.34
$ 0.31 - $ 0.94
546,684
na
40.24M
$ 0.95
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 11-13-2025 09-30-2025 10-Q
2 08-14-2025 06-30-2025 10-Q
3 05-15-2025 03-31-2025 10-Q
4 03-31-2025 12-31-2024 10-K
5 11-14-2024 09-30-2024 10-Q
6 08-14-2024 06-30-2024 10-Q
7 05-13-2024 03-31-2024 10-Q
8 03-25-2024 12-31-2023 10-K
9 11-14-2023 09-30-2023 10-Q
10 08-14-2023 06-30-2023 10-Q
11 05-10-2023 03-31-2023 10-Q
12 03-15-2023 12-31-2022 10-K
13 11-14-2022 09-30-2022 10-Q
14 08-10-2022 06-30-2022 10-Q
15 05-11-2022 03-31-2022 10-Q
16 03-30-2022 12-31-2021 10-K
17 11-10-2021 09-30-2021 10-Q
18 08-11-2021 06-30-2021 10-Q
19 05-11-2021 03-31-2021 10-Q
20 03-22-2021 12-31-2020 10-K
21 11-12-2020 09-30-2020 10-Q
22 08-13-2020 06-30-2020 10-Q
23 05-07-2020 03-31-2020 10-Q
24 02-20-2020 12-31-2019 10-K
25 11-12-2019 09-30-2019 10-Q
26 08-12-2019 06-30-2019 10-Q
27 05-08-2019 03-31-2019 10-Q
28 03-13-2019 12-31-2018 10-K
29 11-07-2018 09-30-2018 10-Q
30 08-13-2018 06-30-2018 10-Q
31 05-10-2018 03-31-2018 10-Q
32 03-01-2018 12-31-2017 10-K
33 11-09-2017 09-30-2017 10-Q
34 08-10-2017 06-30-2017 10-Q
35 05-11-2017 03-31-2017 10-Q
36 03-10-2017 12-31-2016 10-K
37 11-10-2016 09-30-2016 10-Q
38 08-11-2016 06-30-2016 10-Q
39 05-13-2016 03-31-2016 10-Q
40 03-11-2016 12-31-2015 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 hc-wainwright--co-maintains-buy-on-volitionrx-lowers-price-target-to-15

HC Wainwright & Co. analyst Yi Chen maintains VolitionRX (AMEX:VNRX) with a Buy and lowers the price target from $2.5 to...

 d-boral-capital-maintains-buy-on-volitionrx-maintains-5-price-target

D. Boral Capital analyst Jason Kolbert maintains VolitionRX (AMEX:VNRX) with a Buy and maintains $5 price target.

 volitionrx-q3-eps-005-misses-004-estimate-sales-627277k-miss-1681m-estimate

VolitionRX (AMEX:VNRX) reported quarterly losses of $(0.05) per share which missed the analyst consensus estimate of $(0.04) by...

 volitionrx-limited-announces-pricing-of-underwritten-public-offering-of-1155m-shares-of-common-stock-and-accompanying-warrants-at-052-per-unit

VolitionRx Limited (NYSE:VNRX) ("Volition" or the "Company"), a multi-national epigenetics company, announced t...

 levi-strauss-usana-health-sciences-and-3-stocks-to-watch-heading-into-friday

US stock futures up, Apogee Enterprises, Levi Strauss, VolitionRX, USANA Health Sciences, Nurix Therapeutics report results.

 volitionrx-announces-proposed-underwritten-public-offering-of-common-stock-and-common-stock-warrants-no-terms-disclosed

VolitionRx Limited (NYSE:VNRX) ("Volition" or the "Company"), a multi-national epigenetics company, announced t...

 d-boral-capital-maintains-buy-on-volitionrx-maintains-5-price-target

D. Boral Capital analyst Jason Kolbert maintains VolitionRX (AMEX:VNRX) with a Buy and maintains $5 price target.

Core News & Articles

VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, today announces that it ha...

 d-boral-capital-maintains-buy-on-volitionrx-maintains-5-price-target

D. Boral Capital analyst Jason Kolbert maintains VolitionRX (AMEX:VNRX) with a Buy and maintains $5 price target.

 d-boral-capital-maintains-buy-on-volitionrx-maintains-5-price-target

D. Boral Capital analyst Jason Kolbert maintains VolitionRX (AMEX:VNRX) with a Buy and maintains $5 price target.

 volitionrx-q2-eps-006-misses-005-estimate-sales-406688k-beat-379000k-estimate

VolitionRX (AMEX:VNRX) reported quarterly losses of $(0.06) per share which missed the analyst consensus estimate of $(0.05) by...

 volitionrx-may-offer--sell-up-to-30m-of-shares-of-common-stock-from-time-to-time

-  SEC Filing

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION